Home > Healthcare > Biotechnology > Biotechnology R&D > In-vitro Transcription Templates Market

In-vitro Transcription Templates Market Share

Report ID: GMI9684
Published Date: May 2024
Report Format: PDF

Download Free Sample

In-vitro Transcription Templates Market Share

The in-vitro transcription templates sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

In-vitro Transcription Templates Market Companies

Some of the eminent market participants operating in the in-vitro transcription templates industry include:

Agilent Technologies Inc.
Bio-Synthesis Inc.
Bio-Rad Laboratories Inc.
CINVEN LIMITED
Danaher Corporation
Enzynomics Co Ltd.
Enzo Biochem Inc.
F. Hoffmann-La Roche Ltd.
Illumina Inc.
LGC Limited
Merck KGaA
Promega Corporation
Qiagen N.V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

In-vitro transcription templates industry size was worth USD 277.7 million in 2023 and is projected to expand at 19.6% CAGR from 2024 to 2032, owing to the increasing demand for mRNA vaccines and therapeutics.

The DNA templates product segment in the in-vitro transcription templates industry is projected to record USD 571.9 million by 2032, as these templates are highly efficient in driving transcription.

The cancer disease segment in the in-vitro transcription templates industry accounted for USD 90.5 million in 2023 and is projected grow at significant rate from 2024 to 2032, as they are useful for generating large quantities of RNA for functional studies such as examining the roles of oncogenes or tumor suppressor genes in cancer development.

U.S. in-vitro transcription templates industry is projected to reach USD 213.9 million by 2032, led by the strong presence of world-class research institutions, academic centers, and biotechnology hubs for innovation in molecular biology.